CD40 and undifferentiated pleomorphic sarcoma: Moreover, LAG3, IDO1, TNFRSF14, PDCD1LG2, CD86, B2M, CD40 and HAVCR2 were associated with favorable outcomes in UPS patients (Figure 5F).